Self-administered HPV Test Market (2024 - 2034)
Self-administered HPV Test Market Study by DNA Based Assays and RNA Based Assays for Cervical Cancer and Vaginal Cancer for Healthcare Settings, Diagnostic Centers, and Others From 2024 to 2034
Analysis of Self-administered HPV Test Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size Analysis
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain Analysis
The regional analysis includes:
- North America (United States, Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, United Kingdom, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia-Pacific Excluding China and Japan (India, ASEAN, Australia & New Zealand)
- China
- Japan
- The Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
Segmentation of the Self-administrated HPV Test Market Research
-
By Technology :
- DNA-based Assays
- RNA-based Assays
-
By Disease Indications :
- Cervical Cancer
- Vaginal Cancer
-
By End Users:
- Clinics
- Home-based settings
- Healthcare Centers
- Diagnostic Centers
-
By Region :
- Northeast
- Southeast
- West
- Southwest
- Midwest
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. By Test Type
- 6.2. By Indication
- 6.3. By End User
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Test Type
- 7.1. DNA-based HPV Test Kits
- 7.2. RNA-based HPV Test Kits
- 7.3. Hybrid Capture Technology-based Kits
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
- 8.1. Cervical Cancer
- 8.2. Vaginal Cancer
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
- 9.1. Hospitals and Clinics
- 9.2. Home Use
- 9.3. Diagnostic Centers
- 9.4. Reference Laboratories
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. Middle East & Africa
- 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 13. East Asia Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. Sales Forecast 2024 to 2034 by Test Type, By Indication, and By End User for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. F. Hoffmann-La Roche Ltd
- 20.2. Qiagen N.V.
- 20.3. BD (Becton, Dickinson and Company)
- 20.4. Arbor Vita Corporation
- 20.5. Seegene Inc.
- 20.6. Thermo Fisher Scientific
- 20.7. Quest Diagnostics
- 20.8. STI Clinic
- 20.9. Check4Cancer
- 20.10. Rovers Medical Devices
- 20.11. Other Prominent Players
- Frequently Asked Questions -
At what CAGR is the self-administered HPV test market projected to expand?
The global self-administered HPV test market is projected to expand at a CAGR of 18.1% through 2034.
Why is demand for self-administered HPV tests increasing?
Increasing frequency of sexually transmitted illnesses and rising cervical cancer cases in women over the age of 30 are driving self-administered HPV tests demand.
Which region captured a noteworthy market share in 2024?
North America accounted for a 35.7% share of the global market in 2024.
Related Reports
Self-administered HPV Test Market